MY8-23174-28019
2 vaccinations
1 coded response
2 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 530 / WI
- Registered
- 2021-09-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-30
Dose 1 — Pfizer-BioNTech
-
2021-04-20
Dose 2 — Pfizer-BioNTech
-
2021-09-26
Registered in v-safe
-
2021-10-19
Survey response — 6 months, dose 2MedDRA: Chronic sinusitis — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Chronic sinusitisMedDRA releases: 2024-11 · check-in free text available
-
2021-10-19
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-10-25
Call successfulParticipant prefers to complete VAERS report online
- 2022-04-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Pfizer-BioNTech | No |
| 2 | 2021-04-20 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 10 — 6 months, dose 2
Symptoms: Chronic sinusitis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chronic sinusitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release